TRPV1 and diabetes mellitus: Studies in diabetic rodent models, including streptozotocin-induced diabetic rats, obese Zucker rats, and high-fat diet-fed mice, have shown that TRPV1 ablation improves glucose tolerance, reduces obesity, and highlights its potential as a therapeutic target for diabetes and weight management (88).